BioSig Technologies, Inc. is changing its name to Streamex Corp. and trading symbol to "STEX." The rebranding focuses on an expanded business model and growth strategy. The new ticker symbol will be effective at 12:01 am ET on September 12, 2025. The Company's common stock will commence trading on the Nasdaq Capital Market exchange under the new name and trading symbol on the same day.
BioSig Technologies, Inc. has announced a significant rebranding, changing its name to Streamex Corp. and updating its trading symbol to "STEX." The rebranding will take effect at 12:01 am ET on September 12, 2025, with the company's common stock to commence trading on the Nasdaq Capital Market exchange under the new name and trading symbol
BioSig Technologies (BSGM) Rebrands to Streamex Corp with New Ticker STEX[2].
The rebranding reflects a strategic shift in the company's business model and growth strategy. Streamex Corp. will focus on the tokenization of real-world assets and the integration of the gold and commodities market into blockchain technology. This move marks a departure from the company's previous focus on the healthcare sector, particularly within the medical devices and instruments industry
BioSig Technologies (BSGM) Rebrands to Streamex Corp with New Ticker STEX[2].
BioSig Technologies, Inc. has been navigating the competitive landscape of medical technology, with a reported revenue of only $0.01 million and a significant decline in revenue growth over the past few years. The company's financial health presents several areas of concern, with a one-year revenue growth rate of -66.7% and a three-year rate of -71.7%. The company's operating margin, net margin, and EBITDA margin are also negative, indicating substantial financial distress
BioSig Technologies (BSGM) Rebrands to Streamex Corp with New Ticker STEX[2].
The Altman Z-Score of -4.78 places BioSig Technologies in the distress zone, indicating a potential risk of bankruptcy within the next two years. The Piotroski F-Score of 2 and the Beneish M-Score of -0.91 further highlight the company's financial instability and possible financial manipulation
BioSig Technologies (BSGM) Rebrands to Streamex Corp with New Ticker STEX[2].
Despite these challenges, Streamex Corp. aims to leverage its innovative technology, the PURE EP Platform, within a niche market that could offer growth opportunities if operational efficiencies are improved. The company's focus on the tokenization of real-world assets and institutional-grade infrastructure positions it within a rapidly evolving market segment.
Investors should carefully consider the company's financial health and business performance when evaluating its potential for future growth and stability. While the rebranding marks a significant shift in the company's business model, the challenges in revenue generation and financial health remain substantial.
The new ticker symbol "STEX" will replace the current ticker "BSGM" on the Nasdaq Capital Market exchange, reflecting the company's commitment to its expanded business model and growth strategy. Investors can expect the company's common stock to begin trading under this new name and trading symbol on September 12, 2025.
Comments
No comments yet